who leftVCN Biosciences mission is the development of new agents for the treatment of cancer based on oncolytic adenoviruses with high potency and selectivity.


The company develops new candidate viruses from its design, preclinical studies, its production process and early efficacy studies in humans (Phase I and II clinical trials).